Digital Biotechnologies Inc., a new Seattle-based subsidiary of publicly traded immune medicine company Adaptive ...

Adaptive Biotechnologies posted strong Q3 results, beating expectations and reducing losses, while management has done a good job of reducing quarterly cash burn rates. The company's MRD segment, ...

Adaptive Biotechnologies Corporation is rated Hold as MRD segment momentum offset by competitive & valuation concerns. Read ...

This paper estimates a standard Dynamic Stochastic General Equilibrium (DSGE) model that includes a wage and price Phillip's curves with different expectation formation processes for Brazil and the ...

The pandemic has moved us quickly from settled to unsettled. You’ve been cooking and working and teaching and caretaking — the list goes on. And you’re not alone. From individuals, to families, to ...

Chad Robins, left, is co-founder and CEO of Adaptive Biotechnologies, which he co-founded with his brother, Harlan Robins, right, a theoretical physicist turned computational biologist who is the ...

This is a preview. Log in through your library . Abstract Starting from a dynamic optimization principle, the currently most popular approaches to modelling money demand functions are derived. The ...

Adaptive Biotechnologies (ADPT) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to a loss of $0.22 per share a year ago. These ...

In this installment of the mySupport Coping and Thriving series, Anthony Meek, a mySupport clinician, gives guidance on setting realistic goals during stressful times. 2020 was a year that provided ...